ArticlePublic health action2026
From fellows to leaders: lessons learned from the WHO/TDR Clinical Research and Development Fellowship (1999-2021).
Article in Public health action, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundStrengthening research leadership in low- and middle-income countries (LMICs) is essential for addressing diseases of poverty. Since 1999, World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR) has supported this through the Clinical Research and Development Fellowship (CRDF), but evidence on its long-term impact remains limited. We therefore assessed the leadership trajectories of CRDF fellows trained between 1999 and 2021.
methodsAn online cross-sectional survey of CRDF alumni (1999-2021) used a structured questionnaire capturing career progression, productivity, leadership roles, collaborations, institutional contributions, and challenges.
resultsOf 116 fellows contacted, 88 responded (75.8%). More than half had secured competitive funding (55.7%), with a median grant value of USD 512,320 (interquartile range: 111,629-1,200,000; range: USD 700-70,000,000), including multiple national and international awards. Career advancement was notable: 43.2% served as principal investigators and nearly 80% supervised research staff. Many led developments of infrastructure and operating procedures (63.6%). Re-entry grants strengthened institutional capacity for respondents. Collaborations were sustained nationally (77.3%) and through South-South partnerships (71.6%). Almost all fellows (98.9%) continued applying TDR-acquired leadership skills. One third contributed to policy documents. Persistent barriers included difficulty accessing funding, limited institutional support, scarce national funding, and heavy workloads.
conclusionCRDF alumni reported substantial engagement in research leadership, scientific productivity, and institutional capacity strengthening in LMICs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.